Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells

DNA Repair

Volumn 3, Issue 7, 2004, Pages 753-767

  Goodarzi, Aaron A ^a   Lees Miller, Susan P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

A T; ataxia telangiectasia; ataxia telangiectasia mutated; ATM; calf thymus DNA; catalytic subunit of the DNA dependent protein kinase; CT DNA; dithiothreitol; DNA PKcs; double stranded; ds; DTT; high salt buffer; HSB; immunoprecipitation; ionizing radiation; IP; IR

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ATM PROTEIN; CAFFEINE; DOUBLE STRANDED DNA; HELICASE; HEPARIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P53; SERINE; SINGLE STRANDED DNA; WORTMANNIN;

ARTICLE; BLOOM SYNDROME; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANDROSTADIENES; ATAXIA TELANGIECTASIA; CAFFEINE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATOGRAPHY, GEL; CHROMONES; DNA, NEOPLASM; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HELA CELLS; HEPARIN; HUMANS; MOLECULAR WEIGHT; MORPHOLINES; PEPTIDES; PHOSPHORYLATION; POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; SERINE; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 2642543876     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.03.041     Document Type: Article

References (43)

1. Lavin M.F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:1997;177-202
2. Goodarzi A.A., Block W.D., Lees-Miller S.P. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog. Cell Cycle Res. 5:2003;393-411
3. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168
4. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677
5. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679
6. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506
7. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. Embo J. 22:2003;5612-5621
8. E.U. Kurz, S.P. Lees Miller, DNA damage-induced activation of ATM and ATM-dependent signalling pathways, DNA Rep. (Amst.) 3 (2004) doi: 10.1016/j.dnarep.2004.03.029
9. Suzuki K., Kodama S., Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J. Biol. Chem. 274:1999;25571-25575
10. Andegeko Y., Moyal L., Mittelman L., Tsarfaty I., Shiloh Y., Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276:2001;38224-38230
11. Chan D.W., Son S.C., Block W., Ye R., Khanna K.K., Wold M.S., Douglas P., Goodarzi A.A., Pelley J., Taya Y., Lavin M.F., Lees-Miller S.P. Purification and characterization of ATM from human placenta. A manganese-dependent, Wortmannin-sensitive serine/threonine protein kinase. J. Biol. Chem. 275:2000;7803-7810
12. Smith G.C., Cary R.B., Lakin N.D., Hann B.C., Teo S.H., Chen D.J., Jackson S.P. Purification and DNA binding properties of the ataxia- telangiectasia gene product ATM. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11134-11139
13. Llorca O., Rivera-Calzada A., Grantham J., Willison K.R. Electron microscopy and 3D reconstructions reveal that human ATM kinase uses an arm-like domain to clamp around double-stranded DNA. Oncogene. 22:2003;3867-3874
14. Kozlov S., Gueven N., Keating K., Ramsay J., Lavin M.F. ATP activates ATM in vitro: importance of autophosphorylation. J. Biol. Chem. 278:2003;9309-9317
15. Scott S.P., Zhang N., Khanna K.K., Khromykh A., Hobson K., Watters D., Lavin M.F. Cloning and expression of the ataxia-telangiectasia gene in baculovirus. Biochem. Biophys. Res. Commun. 245:1998;144-148
16. Rhodes N., Gilmer T.M., Lansing T.J. Expression and purification of active recombinant atm protein from transiently transfected mammalian cells. Protein Expr. Purif. 22:2001;462-466
17. Ye R., Goodarzi A.A., Kurz E.U., Saito S., Higashimoto Y., Lavin M.F., Appella E., Anderson C.W., Lees-Miller S.P. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. DNA Rep. (Amst.). 3:2004;235-244
18. Chan D.W., Mody C.H., Ting N.S., Lees-Miller S.P. Purification and characterization of the double-stranded DNA-activated protein kinase, DNA-PK, from human placenta. Biochem. Cell Biol. 74:1996;67-73
19. Beamish H., Kedar P., Kaneko H., Chen P., Fukao T., Peng C., Beresten S., Gueven N., Purdie D., Lees-Miller S., Ellis N., Kondo N., Lavin M.F. Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia- mutated protein, ATM. J. Biol. Chem. 277:2002;30515-30523
20. Achari Y., Lees-Miller S.P. Detection of DNA-dependent protein kinase in extracts from human and rodent cells. Methods Mol. Biol. 99:2000;85-97
21. O'Neill T., Dwyer A.J., Ziv Y., Chan D.W., Lees-Miller S.P., Abraham R.H., Lai J.H., Hill D., Shiloh Y., Cantley L.C., Rathbun G.A. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 275:2000;22719-22727
22. Kim S.T., Lim D.S., Canman C.E., Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274:1999;37538-37543
23. Saito S., Goodarzi A.A., Higashimoto Y., Noda Y., Lees-Miller S.P., Appella E., Anderson C.W. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem. 277:2002;12491-12494
24. Sarkaria J.N., Tibbetts R.S., Busby E.C., Kennedy A.P., Hill D.E., Abraham R.T. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent Wortmannin. Cancer Res. 58:1998;4375-4382
25. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:1999;4375-4382
26. Izzard R.A., Jackson S.P., Smith G.C. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res. 59:1999;2581-2586
27. Merkle D., Douglas P., Moorhead G.B., Leonenko Z., Yu Y., Cramb D., Bazett-Jones D.P., Lees-Miller S.P. The DNA-dependent protein kinase interacts with DNA to form a protein-DNA complex that is disrupted by phosphorylation. Biochemistry. 41:2002;12706-12714
28. Soubeyrand S., Torrance H., Giffin W., Gong W., Schild-Poulter C., Hache R.J. Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9605-9610
29. Lindahl T., Satoh M.S., Poirier G.G., Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20:1995;405-411
30. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays. 23:2001;795-806
31. Valenzuela M.T., Guerrero R., Nunez M.I., Ruiz De Almodovar J.M., Sarker M., de Murcia G., Oliver F.J. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene. 21:2002;1108-1116
32. Virag L., Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54:2002;375-429
33. Lees-Miller S.P., Sakaguchi K., Ullrich S.J., Appella E., Anderson C.W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell Biol. 12:1992;5041-5049
34. Gribble F.M., Loussouarn G., Tucker S.J., Zhao C., Nichols C.G., Ashcroft F.M. A novel method for measurement of submembrane ATP concentration. J. Biol. Chem. 275:2000;30046-30049
35. Edelman A.M., Blumenthal D.K., Krebs E.G. Protein serine/threonine kinases. Annu. Rev. Biochem. 56:1987;567-613
36. Dennis P.B., Fumagalli S., Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr. Opin. Genet. Dev. 9:1999;49-54
37. Lees-Miller S.P., Chen Y.R., Anderson C.W. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell Biol. 10:1990;6472-6481
38. Robertson K., Hensey C., Gautier J. Isolation and characterization of Xenopus ATM (X-ATM): expression, localization, and complex formation during oogenesis and early development. Oncogene. 18:1999;7070-7079
39. Hosoi Y., Matsumoto Y., Tomita M., Enomoto A., Morita A., Sakai K., Umeda N., Zhao H.J., Nakagawa K., Ono T., Suzuki N. Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity. Br. J. Cancer. 86:2002;1143-1149
40. Marecki J.C., McCord J.M. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells. Arch. Biochem. Biophys. 402:2002;227-234
41. Shall S., de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model. Mutat. Res. 460:2000;1-15
42. Dantzer F., Menissier-de Murcia J., Barlow C., Wynshaw-Boris A., de Murcia G. Poly(ADP-ribose) polymerase activity is not affected in ataxia telangiectasia cells and knockout mice. Carcinogenesis. 20:1999;177-180
43. Menisser-de Murcia J., Mark M., Wendling O., Wynshaw-Boris A., de Murcia G. Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Mol. Cell. Biol. 21:2001;1828-1832